AMAG snaps up rights to new med Intrarosa to compete with Pfizer’s Premarin® vaginal cream

Tracy Staton reporting for FiercePharma.com writes as follows. AMAG Pharmaceuticals has big ambitions for its women’s health business, so it’s snapped up the rights to a new med, Intrarosa, to beef up that portfolio. The company plans to tout Intrarosa’s safety profile to set it apart from established estrogen-based treatments such as Pfizer’s Premarin cream and… Continue reading AMAG snaps up rights to new med Intrarosa to compete with Pfizer’s Premarin® vaginal cream

Turn your back on Premarin type drugs and seek alternatives for symptoms of menopause

October is Breast Cancer Awareness Month and as it draws to a close we urge women to please turn your backs on Premarin type drugs — tablets and cream — and seek another treatment for menopausal symptoms. There are alternatives. Work with your doctor to find something to help you other than drugs made from… Continue reading Turn your back on Premarin type drugs and seek alternatives for symptoms of menopause